Pfizer's unexpected deal with the Trump administration on drug pricing sends shockwaves through the pharmaceutical industry, pressuring competitors to follow suit amidst potential regulatory threats. What’s next for drug prices?
President Trump announces major changes to prescription drug pricing, with Pfizer leading the way. Discover how U.S. patients will benefit from this new initiative and what it means for the future of healthcare.
In a surprising announcement, Trump declares he will sign an executive order to slash prescription drug prices in the U.S. to match those of other high-income countries, potentially reducing costs by 30% to 80%.
